Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Viracta Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 63 | 1 | 68 | +6 |
| Shares | 13.4M | 43.6K | 15.5M | +2.18M (+16.3%) |
| Value | $151.8M | $495.0K | $124.6M | −$26.7M (−17.7%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Viracta Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Price T Rowe Associates Inc | 1,068,812 | $8.57M | 0.00% |
| Adams Street Partners LLC | 729,509 | $5.85M | 0.75% |
| Blackstone Group Inc. | 238,542 | $1.91M | 0.00% |
| Jasper Ridge Partners, L.P. | 92,939 | $745.0K | 0.03% |
| Hamilton Lane Advisors LLC | 71,491 | $573.0K | 0.10% |
| Franklin Resources Inc | 43,618 | $350.0K | 0.00% |
| Oppenheimer & Co Inc | 38,037 | $305.0K | 0.01% |
| D. E. Shaw & Co., Inc. | 36,262 | $291.0K | 0.00% |
| Jump Financial, LLC | 21,852 | $175.0K | 0.01% |
| SG Americas Securities, LLC | 20,454 | $164.0K | 0.00% |
| Invesco Ltd. | 11,735 | $94.0K | 0.00% |
| State Board of Administration of Florida Retirement System | 10,068 | $81.0K | 0.00% |
| Advisor Group Holdings, Inc. | 4,999 | $39.0K | 0.00% |
| Group One Trading, L.P. | 323 | $3.00K | 0.00% |
Sold out (8)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Sectoral Asset Management Inc | 395,739 | $4.49M |
| Kettle Hill Capital Management, LLC | 185,065 | $2.10M |
| Millennium Management LLC | 27,932 | $317.0K |
| SEI Investments Co | 16,908 | $192.0K |
| Susquehanna International Group, LLP | 14,503 | $164.0K |
| Engineers Gate Manager LP | 10,054 | $114.0K |
| Nisa Investment Advisors, LLC | 3,800 | $43.0K |
| Harbour Investments, Inc. | 42 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 43,618 | $495.0K |